A resolution to declare May 1-7, 2023, as Tardive Dyskinesia Awareness Week in the state of Michigan.
Impact
If adopted, this resolution would not have direct legislative changes or implications on state laws, as it seeks primarily to promote public awareness rather than amend existing laws. However, it represents a significant step towards fostering public education about a commonly underdiagnosed condition, thus potentially influencing public and healthcare policy discussions regarding monitoring and treating patients who are on DRBAs. By raising awareness, it may indirectly lead to more focus on the health implications surrounding psychiatric medications.
Summary
House Resolution 0087 proposes the declaration of May 1-7, 2023, as Tardive Dyskinesia Awareness Week in the state of Michigan. The resolution underscores the importance of awareness regarding tardive dyskinesia (TD), a disorder associated with the prolonged use of dopamine receptor blocking agents (DRBAs), which are commonly prescribed for serious mental health conditions. With an estimated 600,000 individuals affected in the U.S. alone, the resolution aims to shed light on the symptoms and consequences of TD, emphasizing the need for regular screening to ensure timely diagnosis and treatment.
Contention
The notable aspect surrounding Resolution HR0087 is its potential for advocacy and education among the public and healthcare providers. While there may not be significant contention regarding the declaration itself, this resolution serves to elevate the visibility of TD, which could lead to debates about mental health treatment practices and the responsibility of medical professionals to monitor patients more closely. It emphasizes the healthcare system's role in preventing and managing side effects associated with necessary medications.